What's New in Multiple Myeloma?
Updates in Multiple Myeloma
Cilta-cel Boosts Survival in Lenalidomide-Refractory Multiple Myeloma
| Read More |
Teclistamab Extends Survival Vs SOC in Refractory Multiple Myeloma Trial
| Read More |
Optimizing Cellular Therapy Use Across All Stages of Multiple Myeloma
| Read More |
FDA Clears IND Application for KLN-1010 in R/R Multiple Myeloma
| Read More |
Subcutaneous Isatuximab Regimens Show Efficacy in R/R Multiple Myeloma
| Watch Now |